Breaking News

GSK, Sanofi, Takeda, Singapore Researchers Partner to Boost Biologics Innovation

Aims to use research and innovation to grow Singapore's manufacturing capabilities for biologics, including recombinant therapeutic proteins, and vaccines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

GlaxoSmithKline, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore’s biologics manufacturing capabilities.   The partnership will be formalized through the Biologics Pharma Innovation Program Singapore (Bio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters